Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Community Corner
  • Published:

CRISPR technology for gene therapy

Nature Medicine volume 20, pages 476–477 (2014)Cite this article

Subjects

Katherine High

Yin et al.1 have recently reported correction of disease phenotype in a mouse model of hereditary tyrosinemia through hydrodynamic injection of Cas9 nuclease, a single guide RNA and a donor oligonucleotide into mouse liver, resulting in reconstitution of a wild-type Fah gene through genome editing. This represents the first demonstration of the potential utility of this genome-editing system as a therapeutic strategy in vivo.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Yin, H. et al. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat. Biotechnol. published online, doi:10.1038/nbt.2884 (31 March 2014).

  2. Aiuti, A. et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 341, 1233151 (2013).

    Article  Google Scholar 

  3. Tebas, P. et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N. Engl. J. Med. 370, 901–910 (2014).

    Article  CAS  Google Scholar 

  4. Nathwani, A.C. et al. Adenovirus-associated virus vector–mediated gene transfer in hemophilia B. N. Engl. J. Med. 365, 2357–2365 (2011).

    Article  CAS  Google Scholar 

  5. Li, H. et al. In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature 475, 217–221 (2011).

    Article  CAS  Google Scholar 

  6. Wu, Y. et al. Correction of a genetic disease in mouse via use of CRISPR-Cas9. Cell Stem Cell 13, 659–662 (2013).

    Article  CAS  Google Scholar 

  7. Schwank, G. et al. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 13, 653–658 (2013).

    Article  CAS  Google Scholar 

  8. Gaj, T., Gersbach, C.A. & Barbas, C.F. III. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 31, 397–405 (2013).

    Article  CAS  Google Scholar 

  9. Mali, P., Esvelt, K.M. & Church, G.M. Cas9 as a versatile tool for engineering biology. Nat. Methods 10, 957–963 (2013).

    Article  CAS  Google Scholar 

  10. Geall, A.J. et al. Nonviral delivery of self-amplifying RNA vaccines. Proc. Natl. Acad. Sci. USA 109, 14604–14609 (2012).

    Article  CAS  Google Scholar 

  11. Gabriel, R. et al. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat. Biotechnol. 29, 816–823 (2011).

    Article  CAS  Google Scholar 

  12. Snyder, R.O. et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet. 16, 270–276 (1997).

    Article  CAS  Google Scholar 

Download references

Ethics declarations

Competing interests

K.H. has pending patents on ZFN-mediated genome editing in the liver and a patent on the use of AAV vectors to deliver clotting factor genes to the liver. P.D.G. is an employee of Sangamo Biosciences. C.G. is a consultant in the area of genome editing for several companies and an inventor on patent applications related to genome editing for the correction of genetic diseases.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

CRISPR technology for gene therapy. Nat Med 20, 476–477 (2014). https://doi.org/10.1038/nm.3566

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.3566

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research